Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-09 Purchase |
2024-05-13 5:04 pm |
Eledon Pharmaceuticals Inc. | ELDN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
1,927,937 | $0 | $0 | 16,503,731 (Direct) |
View |
| 2023-05-05 Purchase |
2023-05-09 8:25 pm |
Eledon Pharmaceuticals Inc. | ELDN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
1,978,932 | $0 | $0 | 10,496,859 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Hillson Jan Director |
34,300 | $0 | 34,300 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | McBride John S. Director |
34,300 | $0 | 34,300 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
666,500 | $0 | 666,500 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Little Paul Sean Chief Financial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director |
85,750 | $0 | 85,750 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
215,000 | $0 | 215,000 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
270,000 | $0 | 270,000 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Lee June Director |
34,300 | $0 | 34,300 (Direct) |
View |
| 2035-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Robinson James A. Jr. Director |
34,300 | $0 | 34,300 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Kirk Allan Director |
34,300 | $0 | 34,300 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-22 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Little Paul Sean Chief Financial Officer |
525,032 | $0 | 525,032 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-22 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
474,350 | $0 | 474,350 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-22 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
840,438 | $0 | 840,438 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-22 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
1,015,743 | $0 | 1,015,743 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
517,454 | $0 | 517,454 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Little Paul Sean Chief Financial Officer |
267,470 | $0 | 267,470 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
428,148 | $0 | 428,148 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
241,650 | $0 | 241,650 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-03 4:19 pm |
N/A 2033-10-02 |
Eledon Pharmaceuticals Inc. | ELDN | Robinson James A. Jr. Director |
150,437 | $1.55 | 150,437 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-03 4:17 pm |
N/A 2033-10-02 |
Eledon Pharmaceuticals Inc. | ELDN | Kirk Allan Director |
150,437 | $1.55 | 150,437 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:50 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
179,000 | $0 | 179,000 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:50 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
317,147 | $0 | 317,147 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:49 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
383,299 | $0 | 383,299 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:48 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Ogier Walter C Director |
150,437 | $0 | 150,437 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:47 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Little Paul Sean Chief Financial Officer |
198,126 | $0 | 198,126 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:45 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director |
752,185 | $0 | 752,185 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:44 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | McBride John S. Director |
150,437 | $0 | 150,437 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:44 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | LYONS GARY A Director |
150,437 | $0 | 150,437 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:43 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Lee June Director |
150,437 | $0 | 150,437 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:42 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Hillson Jan Director |
150,437 | $0 | 150,437 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 6:11 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
155,000 | $0 | 155,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 6:10 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Ogier Walter C Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 6:08 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | McBride John S. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 6:07 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | LYONS GARY A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 6:05 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Lee June Director |
20,000 | $0 | 20,000 (Direct) |
View |